Vinorelbine induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel - A phase II study

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 1-2, 1996, Pages 150-156

  Fazeny, Barbara ^a   Zifko, Udo ^b   Meryn, Siegfried ^c   Huber, Heinz ^a   Grisold, Wolfgang ^b   Dittrich, Christian ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

^c Evangelisches Krankenhaus Vienna   (Austria)

Author keywords

Breast cancer; Neurotoxicity; Paclitaxel; Vinorelbine

Indexed keywords

NAVELBINE; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CROSS RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; KIDNEY; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PACLITAXEL; REFLEX; SALVAGE THERAPY; VINBLASTINE;

EID: 0029801804     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050551     Document Type: Article

References (29)

1. Belpomme D (1991) Vinorelbine in breast carcinoma: results of an ARTAC phase II trial with special reference to dose intensity and cross resistance with classical drugs. Proceedings, 3rd international congress on neo-adjuvant chemotherapy, Paris, February 6-9
2. Bender RA, Hamel E, Hande KR (1990) Plant alkaloids. In: Chabner BA, Collins JM (eds) Cancer chemotherapy Lippincott, Philadelphia, p 253
3. Besenval M, Delgado M, Demarez JP, Krikorian A (1989) Safety and tolerance of navelbine in phase I-II clinical studies. Semin Oncol 16 [Suppl 4]: 37
4. Binet S, Fellous A, Lataste H, Krikorian A, Couzinier JP, Meininger V (1989) In situ analysis of the action of navelbine on various types of microtubules using immunfluorescence. Semin Oncol 16 [Suppl 4]: 5
5. Brewer F, Warr JR (1987) Verapamil reversal of vincristine resistance and cross-resistance pattern of vincristine-resistant Chinese hamster ovary cells. Cancer Treat Rep 71:353
6. Chaudhry V, Rowinsky EK, Sartorius SE, Ross RN, Donehower C, Cornblath DR (1994) Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35:304
7. Degardin M, Bonneterre J, Hecquet B, Pion JM, Adenis A, Horner D, Demaille A (1994) Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer. Ann Oncol 5:423
8. Dittrich C, Zifko U, Fazeny B, Fiegl M, Grisold W, Huber H (1994) Vinorelbine after paclitaxel in breast cancer: cross-resistance and cumulative neurotoxicity (letter)? Ann Oncol 5:473
9. Dogliotti L, Gorzegno G, Bau MG, Farris A, Bumma C, Botta M, Bottini A, Valzelli S (1993) Vinorelbine as second line treatment in anthracycline pre-treated advanced breast cancer (abstract 430). Eur J Cancer 29A [Suppl 6]: 82
10. Fazeny B, Zifko U, Meryn S, Grisold W, Dittrich C (1994) Navelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel (abstract 29). Proc Am Soc Clin Oncol 13:57
11. Fellous A, Ohayon R, Vacassin T, Binet S, Lataste H, Krikorian A, Couzinier JP, Meininger V (1989) Biochemical effects of navelbine on tubulin and associated proteins. Semin Oncol 16 [Suppl 4]: 9
12. Fisher B, Slack N, Katrych D, et al (1975) Ten year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140:528
13. Fumoleau P, Delgado FM, Delozier T, Monnier A, Gil Delgado MA, Kerbrat P, Garcia-Giralt E, Keiling R, Namer M, Closon MT, Goudier MJ, Chollet P, Lecourt L, Montcuquet P (1993) Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 11:1245
14. Langlois N, Guéritte F, Langlois Y (1976) Applications of a modification of the Polonovski reaction to the synthesis of vinblastine-type alkaloids. J Am Chem Soc 98:7017
15. Le Quesne PM (1993) Neuropathy due to drugs. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds) Peripheral neuropathy, 3rd edn, vol 2. Saunders, Philadelphia London Toronto pp 1571-1581
16. Mathé G. Ribaud P, Gouveia J (1988) Pierre Fabre internal report on navelbine, part IVB 2/38. Pierre Fabre, Boulogne
17. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207
18. National Cancer Institute (1986) Investigators handbood - a manual for participants in clinical trials of investigational agents sponsored by the Division of Cancer Treatment. National Cancer Institute, Bethesda, Maryland
19. Oliveira CF, Cortés Funes H, Lluch A, Lianes P, Gouveia J, Tavares E, Martinez A (1991) Étude, Hispano - portugaise dans le cancer du sein avancé, traitement de deuxième ligne - resultats preliminaires. Proceedings, 3rd international congress on neoadjuvant chemotherapy, Paris, February 6-9
20. Parness J, Horwitz SB (1981) Taxol binds to polymerized tubulin in vitro. J Cell Biol 91:479
21. Potier P (1989) The synthesis of navelbine, prototype of a new series of vinblastine derivates. Semin Oncol 16 [Suppl 4]: 2
22. Roché H, Fumoleau P, Tresca P, Pinon G, Serin D, Marie FN, Delgado M, Belpomme D (1990) Vinorelbine, a new active drug in breast carcinoma: results of an ARTAC phase II trial. Ann Oncol 1 [Suppl]: 36
23. Romero A, Rabinovich MG, Vallejo CT, Perez JE, Rodriguez R, Cuevos MA, Machiavelli M, Lacava JA, Langhi M, Romero Acuna L, Amato S, Barbieri R, Sabatini C, Leone BA (1994) Vinorelbine as first-line chemotherapy for metastatic breast carcinoma. J Clin Oncol 12:336
24. Sarosy G, Kohn E, Stone DA, Rottenberg M, Jacob J, Adamo DO, Ognibene FP, Cunnion RE, Reed E (1992) Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer. J Clin Oncol 10:1165
25. Schaumburg HH, Berger AR, Thomas PK (1992) Laboratory investigation of peripheral nerve disease. In: Schaumburg HH, Berger AR, Thomas PK (eds) Disorders of peripheral nerves, 2nd edn. Davis, Philadelphia, p 33
26. Thomas PK, Eliasson SG (1984) Diabetic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral neuropathy, vol 2. Saunders, Philadelphia London Toronto, p 1773
27. Valagusa P, Bonadonna G, Veronesi A (1978) Patterns of relapse and survival following radical mastectomy. Cancer 41:1170
28. Wiernik PH, Schwartz EL, Einzig A, Strauman JJ, Lipton RB, Dutcher JP (1987) Phase I trial of taxol given as 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol 5:1232
29. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E (1987) Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47:2486